Cargando…

Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study

Objective To determine whether exposure to any antenatal corticosteroids is associated with a lower rate of death at each gestational age at which administration is currently recommended. Design Prospective cohort study. Settings 300 participating neonatal intensive care units of the Pediatrix Medic...

Descripción completa

Detalles Bibliográficos
Autores principales: Travers, Colm P, Clark, Reese H, Spitzer, Alan R, Das, Abhik, Garite, Thomas J, Carlo, Waldemar A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373674/
https://www.ncbi.nlm.nih.gov/pubmed/28351838
http://dx.doi.org/10.1136/bmj.j1039
_version_ 1782518804801126400
author Travers, Colm P
Clark, Reese H
Spitzer, Alan R
Das, Abhik
Garite, Thomas J
Carlo, Waldemar A
author_facet Travers, Colm P
Clark, Reese H
Spitzer, Alan R
Das, Abhik
Garite, Thomas J
Carlo, Waldemar A
author_sort Travers, Colm P
collection PubMed
description Objective To determine whether exposure to any antenatal corticosteroids is associated with a lower rate of death at each gestational age at which administration is currently recommended. Design Prospective cohort study. Settings 300 participating neonatal intensive care units of the Pediatrix Medical Group in the United States. Participants 117 941 infants 23 0/7 to 34 6/7 weeks’ gestational age born between 1 January 2009 and 31 December 2013. Exposure Any antenatal corticosteroids. Main outcomes measures Death or major hospital morbidities analyzed by gestational age and exposure to antenatal corticosteroids with models adjusted for birth weight, sex, mode of delivery, and multiple births. Results Infants exposed to antenatal corticosteroids (n=81 832) had a significantly lower rate of death before discharge at each gestation 29 weeks or less, 31 weeks, and 33-34 weeks compared with infants without exposure (range of adjusted odds ratios 0.32 to 0.55). The number needed to treat with antenatal corticosteroids to prevent one death before discharge increased from six at 23 and 24 weeks’ gestation to 798 at 34 weeks’ gestation. The rate of survival without major hospital morbidity was higher among infants exposed to antenatal corticosteroids at the lowest gestations. Infants exposed to antenatal corticosteroids had lower rates of severe intracranial hemorrhage or death, necrotizing enterocolitis stage 2 or above or death, and severe retinopathy of prematurity or death compared with infants without exposure at all gestations less than 30 weeks and most gestations for infants born at 30 weeks’ gestation or later. Conclusion Among infants born from 23 to 34 weeks’ gestation, antenatal exposure to corticosteroids compared with no exposure was associated with lower mortality and morbidity at most gestations. The effect size of exposure to antenatal corticosteroids on mortality seems to be larger in infants born at the lowest gestations.
format Online
Article
Text
id pubmed-5373674
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-53736742017-04-13 Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study Travers, Colm P Clark, Reese H Spitzer, Alan R Das, Abhik Garite, Thomas J Carlo, Waldemar A BMJ Research Objective To determine whether exposure to any antenatal corticosteroids is associated with a lower rate of death at each gestational age at which administration is currently recommended. Design Prospective cohort study. Settings 300 participating neonatal intensive care units of the Pediatrix Medical Group in the United States. Participants 117 941 infants 23 0/7 to 34 6/7 weeks’ gestational age born between 1 January 2009 and 31 December 2013. Exposure Any antenatal corticosteroids. Main outcomes measures Death or major hospital morbidities analyzed by gestational age and exposure to antenatal corticosteroids with models adjusted for birth weight, sex, mode of delivery, and multiple births. Results Infants exposed to antenatal corticosteroids (n=81 832) had a significantly lower rate of death before discharge at each gestation 29 weeks or less, 31 weeks, and 33-34 weeks compared with infants without exposure (range of adjusted odds ratios 0.32 to 0.55). The number needed to treat with antenatal corticosteroids to prevent one death before discharge increased from six at 23 and 24 weeks’ gestation to 798 at 34 weeks’ gestation. The rate of survival without major hospital morbidity was higher among infants exposed to antenatal corticosteroids at the lowest gestations. Infants exposed to antenatal corticosteroids had lower rates of severe intracranial hemorrhage or death, necrotizing enterocolitis stage 2 or above or death, and severe retinopathy of prematurity or death compared with infants without exposure at all gestations less than 30 weeks and most gestations for infants born at 30 weeks’ gestation or later. Conclusion Among infants born from 23 to 34 weeks’ gestation, antenatal exposure to corticosteroids compared with no exposure was associated with lower mortality and morbidity at most gestations. The effect size of exposure to antenatal corticosteroids on mortality seems to be larger in infants born at the lowest gestations. BMJ Publishing Group Ltd. 2017-03-29 /pmc/articles/PMC5373674/ /pubmed/28351838 http://dx.doi.org/10.1136/bmj.j1039 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research
Travers, Colm P
Clark, Reese H
Spitzer, Alan R
Das, Abhik
Garite, Thomas J
Carlo, Waldemar A
Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
title Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
title_full Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
title_fullStr Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
title_full_unstemmed Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
title_short Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
title_sort exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373674/
https://www.ncbi.nlm.nih.gov/pubmed/28351838
http://dx.doi.org/10.1136/bmj.j1039
work_keys_str_mv AT traverscolmp exposuretoanyantenatalcorticosteroidsandoutcomesinpreterminfantsbygestationalageprospectivecohortstudy
AT clarkreeseh exposuretoanyantenatalcorticosteroidsandoutcomesinpreterminfantsbygestationalageprospectivecohortstudy
AT spitzeralanr exposuretoanyantenatalcorticosteroidsandoutcomesinpreterminfantsbygestationalageprospectivecohortstudy
AT dasabhik exposuretoanyantenatalcorticosteroidsandoutcomesinpreterminfantsbygestationalageprospectivecohortstudy
AT garitethomasj exposuretoanyantenatalcorticosteroidsandoutcomesinpreterminfantsbygestationalageprospectivecohortstudy
AT carlowaldemara exposuretoanyantenatalcorticosteroidsandoutcomesinpreterminfantsbygestationalageprospectivecohortstudy